In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus

In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus

LCB01-0648 is a novel oxazolidinone compound that shows potent antibacterial activities against most Gram-positive cocci, including the multi-drug resistant Staphylococcus aureus. In this study, in vivo activity of LCB01-0699, a LCB01-0648 prodrug, against S. aureus was evaluated in comparison with...

Full description

Bibliographic Details
Main Authors: Sang-Hun Oh, Hee-Soo Park, Jun-Hyung Lee, Sung-Yun Baek, Sang-Eun Chae, Kyuman Oh, Young Lag Cho, Jin-Hwan Kwak
Format: Article
Language:English
Published: MDPI AG 2017-11-01
Series:Molecules
Subjects:
LCB01-0699
LCB01-0648
oxazolidinone
in vivo activity
skin infection
Online Access:https://www.mdpi.com/1420-3049/22/12/2096

Internet

https://www.mdpi.com/1420-3049/22/12/2096

Similar Items